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Abstract: The purpose of this review was to evaluate the current state of the literature and to identify
the types of study designs, wearable devices, statistical tests, and exercise modes used in validation
and reliability studies conducted in applied settings/outdoor environments. This was performed
according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)
guidelines. We identified nine articles that fit our inclusion criteria, eight of which tested for validity
and one tested for reliability. The studies tested 28 different devices with exercise modalities of
running, walking, cycling, and hiking. While there were no universally common analytical techniques
used to measure accuracy or validity, correlative measures were used in 88% of studies, mean absolute
percentage error (MAPE) in 75%, and Bland–Altman plots in 63%. Intra-class correlation was used
to determine reliability. There were not any universally common thresholds to determine validity,
however, of the studies that used MAPE and correlation, there were only five devices that had a
MAPE of < 10% and a correlation value of > 0.7. Overall, the current review establishes the need for
greater testing in applied settings when validating wearables. Researchers should seek to incorporate
multiple intensities, populations, and modalities into their study designs while utilizing appropriate
analytical techniques to measure and determine validity and reliability.
Keywords: fitness tracker; activity monitor; biometric technology; biosensors; systematic review;
field; outdoor; exercise physiology
1. Introduction
Advances in technology have allowed researchers to learn how the body reacts to the stresses
placed upon it through sport, physical activity, and exercise. Laboratory technology has advanced
from early direct calorimeters, to whole-room open-circuit indirect calorimeter, to Douglas Bags,
then pedometers, metabolic carts, portable metabolic systems, and other means designed to measure
physiological metrics during exercising [1,2]. Technologies like Douglas Bags and portable metabolic
systems have been revolutionary to the field of exercise physiology, allowing research to be performed
in applied settings. This has enabled researchers to take the athletes or participants into the field
to measure the physiological responses to the stresses of exercise. Wearables and fitness trackers
are the natural progression to this technology, with the added benefit of reduced cost and increased
prevalence. With the popularity of wearable technology increasing year over year, there are unique
opportunities and insights now available. As these fitness trackers are meant to be worn by the
general public, continuously, they provide a wealth of new data, previously unavailable to sport and
exercise scientists, public health and wellness experts, and medical professionals. A total of 722 million
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connected wearable devices existed, worldwide, in 2019 [3]. The potential of this technology can
revolutionize exercise physiology research, allowing researchers to ask more detailed and granular
questions, and achieve a level of data acquisition that was previously out of reach [4].
Despite the potential of wearable technology to influence physiology research, there remains
a need to ensure accuracy and reliability through independent research. Consumer devices have
developed the ability to measure or estimate a range of physiological metrics, including heart rate
variability, stress, pulse oximetry, lactate threshold, calorie consumption, and electromyography.
This provides an advantage to future research potential as they will enable researchers to gain a deeper
understanding of the body. However, we are currently limited in our use of these technologies without
the independent validation of these devices. Unfortunately, independent validation has not kept pace
with industry offerings, with companies producing and releasing devices faster than researchers can
test for validity and reliability [5,6]. Whether the device produces valid estimates or measures is a
matter of great concern to consumers and researchers desiring to utilize this technology. As the demand
for accurate wearable technology has increased, independent validation has increased too, but at
different rates [7,8]. The issue of determining validity is also compounded by the novelty of the field,
and widely established validity criteria have not been determined. The statistical tests performed by
researchers are also widely varied, and at times, inappropriate, indiscriminate, and unable to determine
the validity of the device being tested. Standardized analytical methods have been suggested [9,10],
and progress has been made, as of late, to remedy the deficiency in proper statistical tests.
There have been a number of reviews or analyses performed on wearable technology on topics
such as wearable technology in sports and performance [11,12], its influence on human behavior [13–16],
in medicine [17], and its use in elderly populations [18,19], among many others [20–26]. There has
yet to be a review, to our knowledge, that has focused on studies validating the devices in applied or
field-based settings. As discussed earlier, the role of these portable wearable devices is to measure
physiological metrics in real-world applications, yet there is a clear gap in the research validating
devices in applied settings. Therefore, the purpose of this review is to evaluate the current state of the
literature and to identify the types of study designs, wearable devices, statistical tests, and exercise
modes used in validation and reliability studies conducted in applied settings/outdoor environments.
2. Materials and Methods
This review was conducted in accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) guidelines [27]. According to Sutton et al. [28] this review
would be defined as a rapid review due to the limitations listed in the discussion. The review protocol
has been published previously in accordance with the PRISMA guidelines [29].
2.1. Inclusion Criteria
For an article to be included, it had to satisfy six requirements: (1) have an exercise component,
(2) utilize wearable technology to provide physiological measures, (3) include a statistical measure
of validity or reliability, (4) be conducted outdoors, (5) be available in English, and (6) be published
after 2010. For the purposes of this review, we adopted the American College of Sports Medicine
definition of exercise, “Exercise is a type of [physical activity] consisting of planned, structured,
and repetitive bodily movement done to improve and/or maintain one or more components of physical
fitness” [30], if the study did not include a form of exercise that met this definition, it was not included.
Wearable technology was defined as any wearable technological device capable of returning any
physical or physiological metric to the user. Physiological measures were defined as any measurable
physiological process occurring within the body, which would include measures such as heart rate,
energy expenditure, and lactate threshold, but would exclude physical measurements such as step
count, distance, cadence, and repetitions. The timeline of 2010 as well as from more recently was
chosen because prior to 2010, wearable technology was much less sophisticated than what is seen today,
which has developed into devices capable of measuring or estimating more complex physiological
Technologies 2020, 8, 70 3 of 15
variables. The purpose was to represent the current state of the technology, and due to the rapid
evolution of this technology, anything prior to 2010 is antiquated and too different from the devices
being released today.
2.2. Search Strategy
Researchers performed three phases of screening, and teams of two independent reviewers
performed all searches and reviews. First, the researchers identified all relevant articles by title
screening only; second, eligibility was determined by abstract screening; and finally, full-article
screening was performed. Any inconsistencies in eligible literature within teams was rectified by
a third researcher. Reviewers exported the references into the citation manager of their choice
(RefWorks or Endnote), then sent their completed list as an excel spreadsheet (exported from the
citation manager) to the third researcher for the compilation and determination of final eligibility to
resolve any inconsistencies. If eligibility could not be determined from the text, reviewers contacted
the author by email to clarify; there were no instances where the author could not be contacted
for clarification.
Google Scholar was used as the search database, and the single search string which utilized
keywords and Boolean operators was: “Running OR Walking OR Biking OR Cycling OR Swimming
OR Rowing OR Hiking OR Triathlon OR Exercise + Activity Trackers OR Fitness Trackers OR Wearable
Technology OR Wearables + Validity OR Reliability OR outdoors OR field” (see Table 1).
Table 1. Required components with the accompanying search terms utilized.
Exercise Format Technology Term Statistical Measure Natural Environment
Biking Activity Trackers Reliability Field









Teams of two independent reviewers extracted relevant data from each study into an excel
spreadsheet, including information such as the number of subjects, information on the wearable device
being tested, statistical measures to determine validity, outdoor location, as well as exercise format and
intensity. Any inconsistencies were resolved between the reviewers on that team.
2.4. Risk of Bias Assessment
The Cochrane Risk of Bias Tool 2.0 (ROB 2.0) was used to assess the methodological quality of
the individual studies and the risk of bias [31]. Teams of two researchers collaborated to fill out the
assessment tool for each study.
3. Results
The search string resulted in 17,300 articles. During the screening process, it became known to the
researchers that Google Scholar does not allow users to go past 100 pages (1000 articles). Therefore,
while the search produced 17,300 results, 1000 results were evaluated for inclusion. This limitation
was not known prior to choosing Google Scholar as the database, but due to the popularity of Google
Scholar, (82% of academic knowledge seekers start their research with Google Scholar) [32], the size
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of Google Scholar [33], and the scope of the rapid review being performed, we determined that this
would be a sufficient assortment of articles for the current rapid review.
There was a total of 157 articles after title screening, 38 articles after abstract screening, and a total
of nine articles that met the criteria for inclusion after full-article screening, [34–42] (see Figure 1 and
Table 2).
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Table 2. Devices used by the author, location of use and company information.
Author Device Company Information Location
Adamakis (2017) Garmin Forerunner 310XT withChest HR Monitor Garmin Ltd., Olathe, KS, USA
Wrist and
Chest
Carrier et al. (2020) Garmin fēnix 3 HR + Chest HRM Garmin Ltd., Olathe, KS, USA Wrist
Montes et al. (2015) Hexoskin Biometric Shirt Carré Technologies Inc., Montreal,QC, Canada Torso
Navalta et al. (2020) Garmin fēnix 5 Garmin Ltd., Olathe, KS, USA Wrist
Navalta et al. (2020) Jabra Elite Sport Earbuds Jabra, Copenhagen, Denmark Ears
Navalta et al. (2020) Motiv Ring Motiv Inc., San Francisco, CA, USA Hand
Navalta et al. (2020) Scosche Rhythm+ Forearm Band Scosche Industries Inc., Oxnard, CA, USA Forearm
Navalta et al. (2020) Suunto Spartan Sport Watch +Chest HRM Suunto Oy, Vantaa, Finland
Wrist and
Chest
Parak et al. (2017) PulseOn PulseOn, Espoo, Finland Wrist
Tanner et al. (2016) Hexoskin Biometric Shirt Carré Technologies Inc., Montreal,QC, Canada Torso
Wahl et al. (2017) BodyMedia Sensewear MF BodyMedia Inc., Pittsburgh, PA, USA Upper Arm
Wahl et al. (2017) Beurer AS80 Beurer GmbH, Ulm, Germany Wrist
Wahl et al. (2017) Polar Loop Polar Corp., Worcester, MA, USA Wrist
Wahl et al. (2017) Garmin Vivofit Garmin Ltd., Olathe, KS, USA Wrist
Wahl et al. (2017) Garmin Vivosmart Garmin Ltd., Olathe, KS, USA Wrist
Wahl et al. (2017) Garmin Vivoactive Garmin Ltd., Olathe, KS, USA Wrist
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Table 2. Cont.
Author Device Company Information Location
Wahl et al. (2017) Garmin Forerunner 920XT Garmin Ltd., Olathe, KS, USA Wrist
Wahl et al. (2017) Fitbit Charge Fitbit Inc., San Francisco, CA, USA Wrist
Wahl et al. (2017) Fitbit Charge HR Fitbit Inc., San Francisco, CA, USA Wrist
Wahl et al. (2017) Xiaomi Mi Band Xiaomi Corp., Beijing, China Wrist
Wahl et al. (2017) Withings Pulse Ox Withings SACA, Issy LesMoulineaux, France Wrist
Xie et al. (2018) Apple Watch 2 Apple Inc., Cupertino, CA, USA Wrist
Xie et al. (2018) Samsung Gear S3 Samsung Electronics Co., Ltd., Seoul,South Korea Wrist
Xie et al. (2018) Jawbone Up 3 Jawbone Inc., Beverly Hills, CA, USA Wrist
Xie et al. (2018) Fitbit Surge Fitbit Inc., San Francisco, CA, USA Wrist
Xie et al. (2018) Huawei Talk Band B3 Huawei Technologies Co., Ltd., LonggangDistrict, Shenzhen, China Wrist
Xie et al. (2018) Xiaomi Mi Band 2 Xiaomi Corp., Beijing, China Wrist
Zanetti et al. (2014) BodyMedia SenseWear MiniArmband BodyMedia Inc., Pittsburgh, PA, USA Wrist
3.1. Exercise Mode
The studies reviewed utilized several exercise modalities to test for validity or reliability,
including walking or hiking [34,36,41,42], running or trail running [34,37–42], and cycling [41]
(See “Exercise Modality” column in Tables 3–5). These activities were performed under various
intensities and durations.
Table 3. Estimated energy expenditure validity of wearable devices in an outdoor setting. r = Pearson
correlation coefficient, MAPE = mean absolute percentage error, MAE = mean absolute error, TE = typical
error, ICC = intraclass correlation coefficient, LoA = levels of agreement. Values for MAPE are shown
as originally reported by the authors.
Author Wearable Device Exercise Modality Validity Measure
Adamakis (2017) Garmin Forerunner 310XT Walking MAPE = 17.39%
Adamakis (2017) Garmin Forerunner 310XT Running MAPE = 17.32%
Parak et al. (2017) PulseOn Running Bias: −11.93+13.99, MAE = 13.05,MAPE = 16.5%, r = 0.77
Tanner et al. (2016) Hexoskin Biometric Shirt Trail Running r = −0.058
Wahl et al. (2017) Bodymedia Sensewear MF Running MAPE = −20.8%, ICC = 0.43, TE = 21.8,LoA = 9.7 to −103.6
Wahl et al. (2017) Polar Loop Running MAPE = 22.1%, ICC = −0.18, TE = 71.4,LoA = 163.0 to −94.8
Wahl et al. (2017) Beurer AS80 Running MAPE = −48.4%, ICC = −0.04, TE = 56.8,LoA = 1.3 to −216.9
Wahl et al. (2017) Garmin Vivofit Running MAPE = −20.2%, ICC = 0.56, TE = 14.3,LoA = −1.9 to −86.6
Wahl et al. (2017) Garmin Vivosmart Running MAPE = −1.5%, ICC = 0.82, TE = 13.6,LoA = 59.0 to −66.8
Wahl et al. (2017) Garmin Vivoactive Running MAPE = −4.5%, ICC = 0.91, TE = 5.4,LoA = 24.3 to −46.2
Wahl et al. (2017) Garmin Forerunner 920 XT Running MAPE = −21.2%, ICC = 0.34, TE = 31.9,LoA = 29.3 to −124.5
Wahl et al. (2017) Fitbit Charge Running MAPE = −4.5%, ICC = 0.64, TE = 18.6,LoA = 46.2 to −75.6
Wahl et al. (2017) Fitbit Charge HR Running MAPE = −12.0%, ICC = 0.53, TE = 24.4,LoA = 40.2 to −99.5
Wahl et al. (2017) Withings Pulse Ox (Hip) Running MAPE = −5.5%, ICC = 0.21, TE = 52.0,LoA = 97.3 to −132.2
Wahl et al. (2017) Withings Pulse Ox (Wrist) Running MAPE = −4.5%, ICC = 0.22, TE = 50.0,LoA = 91.7 to −130.4
Xie et al. (2018) Jawbone Up3 Running, Walking,Cycling MAPE = 28%
Xie et al. (2018) Huawei Talk Band B3 Running, Walking,Cycling MAPE = 32%
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Table 3. Cont.
Author Wearable Device Exercise Modality Validity Measure
Xie et al. (2018) Samsung Gear S3 Running, Walking,Cycling MAPE = 38%
Xie et al. (2018) Xiaomi Mi Band 2 Running, Walking,Cycling MAPE = 40%
Xie et al. (2018) Apple Watch 2 Running, Walking,Cycling MAPE = 49%
Xie et al. (2018) Fitbit Surge Running, Walking,Cycling MAPE = 67%
Zanetti et al. (2014) BodyMedia SenseWear MiniArmband
Rugby Intermittent
Exercise Test r = 0.55
Table 4. Heart rate reliability and the validity of wearable devices in an outdoor applied setting.
CCC = Lin’s concordance correlation coefficient.
Author Wearable Device Exercise Modality Reliability/Validity Measure
Montes et al. (2015) Hexoskin Smart Shirt(reliability) Hiking (Average Heart Rate) ICC = 0.73
Montes et al. (2015) Hexoskin Smart Shirt(reliability) Hiking (Maximal Heart Rate) ICC = 0.68
Navalta et al.
(2020) Garmin Fenix 5 Trail Running
MAPE = 13.5%, MAE = 20.8
bpm, CCC = 0.316, ICC = 0.415
Navalta et al.
(2020) Jabra Elite Sport Trail Running
MAPE = 21.3%, MAE = 30.0
bpm, CCC = 0.384, ICC = 0.395
Navalta et al.
(2020) Motiv Ring Trail Running
MAPE = 15.9%, MAE = 25.1
bpm, CCC = 0.293, ICC = 0.287
Navalta et al.
(2020) Scosche Rhythm+ Trail Running
MAPE = 5.6%, MAE = 7.3 bpm,





MAPE = 1.9%, MAE = 2.9 bpm,
CCC = 0.955, ICC = 0.955
Tanner et al. (2016) Hexoskin Smart Shirt Trail Running r = −0.012 to 0.354
Xie et al. (2018) Samsung Gear S3 Running, Walking, Cycling MAPE = 4%
Xie et al. (2018) Apple Watch 2 Running, Walking, Cycling MAPE = 7%
Xie et al. (2018) Fitbit Surge Running, Walking, Cycling MAPE = 8%
Xie et al. (2018) Xiaomi Mi Band 2 Running, Walking, Cycling MAPE = 12%
Table 5. Validity of wearable devices in an outdoor setting, evaluating various physiological measures.
Author Physiological Variable Wearable Device Exercise Modality Validity Measure
Carrier et al. (2020) VO2max
Garmin fenix 3
HR Running MAPE = 8.05%, r = 0.917
Parak et al. (2017) VO2max PulseOn Running
−1.07+2.75, MAE = 2.39,
MAPE = 5.2%, r = 0.86
Tanner et al. (2016) Ventilation Rate Hexoskin Trail Running r = 0.678 to 0.937
Tanner et al. (2016) Minute Ventilation Hexoskin Trail Running r = −0.020 to 0.146
Duration was reported as both distance (km) and time (min). The average reported running
distance was 2.2 ± 1.3 km, while the average walking distance was 2.1 ± 1.4 km. Distance was
not reported for cycling exercise [41]. Six articles [34,35,37,38,40,42] reported time as their
measure of duration with Navalta et al. [37] and Adamakis [34] both reporting duration and time.
Adamakis reported a timed duration for two different exercise protocols, walking and running
(which were each factored into the average separately). Among the articles that reported time as their
measurement, an average of 25.1 min was spent performing the study-specific protocols.
The intensities under which the participants performed the activities were primarily described as
a generalized, self-selected pace. Carrier et al. [35] was among the articles that described a self-selected
pace for their participants but included a stipulation that the pace be maintained above 70% of the
subject’s maximal heart rate. This was in accordance with the guidelines of the wearable technology
utilized to estimate aerobic capacity. Other exercise intensity descriptions by authors included
Wahl et al. [40], who described in their protocol as an outdoor run that needed to be maintained at a
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speed of 10.1 km/h, and Zanetti et al. [42], who described the exercise as a specific, intermittent intensity
that would simulate the intensity of running/exercising in a rugby match as their exercise protocol.
3.2. Study Design
With respect to the study design employed by the investigations meeting the criteria for inclusion
in this rapid review, the data extracted were participant characteristics, types of statistical analyses,
criterion measures used, and physiological variables tested.
The number of participants utilized for determining the validity and reliability of wearable devices
in an outdoor/applied setting ranged from n = 1 to n = 44 (n = 19.6 ± 12 participants, reported as mean
± SD). Only 56% (5/9) of studies had over 20 participants. Seventy-seven percent of studies (7/9) tested
both male (n = 11 ± 6) and female (n = 9 ± 7) participants. Participants in all investigations were
overwhelmingly younger, with an average mean age of 27± 5 years. Without exception, the participants
were screened to be healthy and free of illness. Four investigations (57%) required participants to have
a state of chronic activity level. The studies reviewed for this paper all included information on the
biological sex, age, weight, and height of the participants, as is commonly reported, with Parak et al. [38]
also reporting body mass index (BMI), Wahl et al. [40] and Zanetti et al. [42] both reporting body fat
percentage, Xie et al. [41] reporting weekly physical activity, and Carrier et al. [35] reporting weekly
average run distance.
One investigation evaluated wearable device reliability, and the remaining reported validity
compared to a criterion measure [36] (See “Reliability/Validity Measure” column in Tables 3–5).
Reliability was determined using the intraclass correlation coefficient (ICC) and measures were
considered reliable if the ICC was greater than 0.70 with an accompanying p-value less than 0.05.
Considering validity measurements, 88% (7/8) of studies used multiple indicators of agreement.
Four investigations [34,35,41,42] reported two measures of validity, while three studies [37,38,40]
utilized four statistical tests or more for agreement. Among the statistical tests, correlative measures
(Pearson, ICC, Spearman, Lin’s concordance correlation coefficient (CCC)) were employed in 88% (7/8)
of studies with established thresholds for considering a device valid either using statistical significance
(p < 0.05) or a predefined definition (r > 0.70). Mean absolute percent error (MAPE) was used in 75%
(6/8) of studies with a threshold of lower than 10% being considered valid in two studies, and thresholds
not reported in the methodology in the remaining four investigations. The typical error of the estimate
(TEE) or mean absolute error (MAE) was employed in four investigations with effect size calculations
used to determine the validity thresholds in one study and thresholds not reported in the remaining
three investigations. Bland–Altman plots were utilized in 63% (5/8) of investigations.
The single investigation that determined reliability in an outdoor setting evaluated pulmonary
variables (respiratory rate, maximal respiratory rate), cardiovascular variables (heart rate, maximal
heart rate), and energy expenditure [36]. The majority of studies aimed at determining wearable
device validity obtained energy expenditure estimates (80%, 6/8) (See Table 3). The criterion equipment
utilized were portable metabolic analyzers that were validated against laboratory-based systems [43–45]
Cosmed K4b2 (COSMED, Rome, Italy) (67%, 4/6), Metalyzer 3b (Cortex Medical, Leipzig, Germany)
(17%, 1/6), and Metamax 3b (Cortex Medical, Leipzig, Germany) (17%, 1/6). Three investigations
(38%, 3/8) determined a heart rate agreement [37,39,41] with the valid and reliable Polar heart rate
monitors [46,47] utilized as the criterion in two studies [37,39], and manual palpation utilized in the
other [41] (See Table 4). Two investigations determined the validity of a wearable device to return
accurate maximal aerobic capacity (VO2max) (25%, 2/8) [35,38], while one investigation determined
the validity for ventilatory rate (17%, 1/6) and pulmonary ventilation (17%, 1/6) (39) (See Table 5).
The criterion measure employed for these variables was a portable metabolic cart (Metalyzer 3b,
Cosmed K4b2) or laboratory metabolic cart (Parvo Medics TrueMax, Sandy, UT, USA).
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3.3. Wearable Device
From all studies reviewed, a total of 28 consumer devices tested and no novel devices were used
(a total list of devices can be found in Table 2). In studies with multiple devices being tested [34,37,40,41],
the order in which they were placed on the wrist/forearm were randomized. Of the devices tested
only one was biometric clothing (Hexoskin), one ring (Motiv Ring), one forearm (Scosche Rhythm+),
one earbud (Jabra Elite Sport Earbuds), and 24 were wrist-worn devices (see Table 2).
3.4. Device Validity
Device validity was determined for several different physiological metrics, including energy
expenditure, heart rate, ventilation rate, VO2max, and minute ventilation.
3.4.1. Estimated Energy Expenditure
As shown in Table 3, the energy expenditure estimations from wearable technology devices
continued to have low agreement with criterion portable metabolic units when this measure was
obtained in an outdoor environment. Of the twenty-three different wearable devices evaluated
in the literature to meet inclusion in the present rapid review, none were considered to return
acceptable validity measures for exercise occurring in a natural setting, according to the authors of the
original studies. Additionally, no investigations reported reliability measures for estimated energy
expenditure outdoors.
3.4.2. Heart Rate
Heart rate measures depend largely on the device type and outdoor location utilized. The Hexoskin
smart shirt displayed poor reliability (36) and validity (39) when utilized in trail situations (hiking and
trail running). Similarly, every photoplethysmography-based device evaluated during trail running
returned heart rate values that were not deemed acceptable by the authors (37). On the other hand,
with the exception of the Xiaomi Mi Band 2, wrist worn devices returned acceptable agreement when
compared to palpated heart rate measurements when participants ran and walked around a track or
rode a fixed path [41] (see Table 4).
3.4.3. Other Physiological Variables
One investigation evaluated the ability of wearable technology devices to return acceptable validity
measures for the estimated physiological variables of ventilation rate, and minute ventilation [39],
while two evaluated VO2max [35.38]. The Hexoskin biometric shirt displayed acceptable agreement
for ventilation rate but not minute ventilation [39] in a trail environment. The PulseOn monitor
and Garmin fenix 3 provided acceptable validity for estimating the maximal aerobic capacity when
participants ran on an outdoor track [35,38] (see Table 5). No reliability data were available for these
variables in an outdoor setting.
3.5. Outdoor Location/Environment
Of the studies reviewed, various outdoor locations were chosen and are as follows: outdoor trails
(4/9) [34,36,37,39], paved track (3/9) [35,38,41], free-living conditions [40], and a rugby field (1/9) [42].
All studies had varying descriptions of the environment. Of the studies reviewed, Adamakis [34],
Montes et al. [36], Navalta et al. [37], and Tanner et al. [39] were the only studies to mention grade or
elevation, with Adamakis taking place at a 49-acre park on a path with both wooden and paved surfaces
with no increase or decrease in grade. Montes noted the starting elevation for both days, where day
one was recorded at 5446 feet above sea level, and day two was recorded as 5757 feet above sea level
at the trailhead, which then rose to 6443 feet above sea level at a 17.6% grade. The trail names were
not mentioned, however, a grading system was defined for both trails as a class I, Yosemite Decimal
System (YDS). Navalta et al. took place at three separate locations: McCullough Hills Trail, Henderson,
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NV, with an elevation change of 58 m, Three Peaks Trail, Cedar City, UT, at 55 m, and Bristlecone
Trail, Mt. Charleston, NV, at 104 m. Navalta et al. were also the only study that included graphs and
explanations of the elevation gain and drop along the trail path. The Tanner et al. study took place at
Three Peaks Recreation Area, Cedar City, with a starting elevation of 5385 feet above sea level with a
rise of 56 feet.
Parak et al. [38] and Tanner et al. [39] were the only studies to mention temperature whereas
Tanner et al.’s was measured at 26.2–32.3 ◦C. Parak et al. did not give a specific temperature but listed
stipulations for conducting testing, since testing took place in the winter months. The stipulations
were no rain or snow, and a temperature above −10 ◦C.
The study by Zanetti et al. [42] took place on a rugby pitch to simulate game aspects, but no
other information about climate or environment was given. Wahl et al. [40] also did not describe the
environment of their outdoor running route. Xie et al. [41] used a standard 400 m track for part of the
testing, though they did not describe their predetermined outdoor cycling route.
Environment was not explicitly described for every study and/or session, but inferences could
be made by the geographical location of each study. Adamakis (Athens, Greece), Montes et al.
(United States), Navalta et al. (Las Vegas, NV), Parak et al. (Finland), Carrier et al. (Utah), Tanner et al.
(Cedar City, UT, USA), Wahl et al. (Germany), Xie et al. (China), and Zanetti et al. (Australia).
3.6. Risk of Bias
The risk of bias and methodological quality of the studies included in the present review were
assessed using the Cochrane Risk of Bias Assessment Tool (ROB 2.0) [31]. The assessment tool uses five
domains to evaluate the quality of the study and the individual risk of bias (1. randomization process,
2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the outcome,
5. selection of the reported result), which produces an overall bias result in the form of “Low risk”,
“Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies had at least
“Some concerns” for bias due to the randomization procedures being irrelevant to validation-type
study designs. One study had a high risk of bias due to the sample size of one (n = 1) (34).
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias of
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outc m , 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (  = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produ es an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality an  the ri k of bias 










































































































     















Technologies 2020, 8, x FOR PEER REVIEW 11 of 17 
 
process, 2. deviations from intended interventions, 3. missing outco e data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “So e concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the ra domization procedures bei g irrelevant to 
validation-type study designs. One study had a high risk of bias due t  the sample siz  of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended in erventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to the randomization procedures being irrelevant to 
vali ation-type study designs. One study had a high ri k of bias due to t e sample size of on  (n = 1) 
(34). 
Table 6. Cochrane Risk of Bia Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended in erventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of t e reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/ nclear risk of i s, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to the ran omization procedures being irrelevant to 
vali ation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of B a Assessment tool output us d to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which pro uces an overall bias re ult in the form of 
“Low risk”, “Some concerns”/unclear risk f bias, and “High risk”, as s e  in Table 6. All the studies 
had at least “Some concerns” f r bias d e to the ra domization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias t  the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcom  d a, 4. measurement of he 
outcome, 5. selection of the reported result), w ic  produ es an overa l bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Tabl  6. All the studies 
had at least “Some concerns” for bias due to the randomiz ion procedures being irrelevant to 
validation-type study designs. One tudy had a hig  risk of bi  due o the sampl  size of ne (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outco e data, 4. measurement of the 
outcome, 5. selection of the reported result), w ich produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to th  ra dom zation procedures be g irrelevant to 
validation-type study designs. One st dy had a high risk of bias due to the sampl  size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess th  quality and the risk of bias 
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process, 2. deviatio s from inte ded interventio s, 3. missing outcome data, 4. measurement of the 
outcom , 5. selectio  f the reported result), w ic  pr duces an overall bias result in th  form of 
“Low risk”, “Some c ncerns”/ nclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias ue to the randomization procedures being irrelevant to 
vali ation-type st dy design . One t dy h  a igh risk of bi  due to the sample size f ne (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations fr m intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the rep rted result), w ich roduces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear  of bias, and “High ris ”, as een in Table 6. All the studies 
had at least “Some concern ” for bi s due t  the randomization procedures being irrelevant to 
vali ation-type st dy desi ns. One st dy had a igh risk of bia  due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessme t tool o tput us d to as ess the q ality an  the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Som  concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All t e studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended i terventi s, 3. mis ing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), wh ch pro uce  an overall bias result in the f r  of 
“Low risk”, “Some concerns”/unclear risk f bias, and “High risk”, as s e in Table 6. All the tud es 
had at least “Some concerns” f r bia  d e to the ra domization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias e t  the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result i  the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. On  study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outco e data, 4. measurement f the 
outcome, 5. selection of the reported result), w ic  produces an overall bias esult in the f rm of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the ra domization procedures bei g irrelevant to 
validation-type study designs. One t dy had a high ri k of bi  ue t the sample size of ne (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used t  assess the q ality and the risk of bias 
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pr cess, 2. deviations from intended i erventions, 3. missing outcome da a, 4. measurement of the 
outcom , 5. selectio  of the reported r ult), wh ch pr duces an ov rall bias result in the form of 
“Low risk”, “Some c ncerns”/ nclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” f r bias e to the randomizatio  procedures being irrelevant to 
vali ation-type st dy designs. One st dy ha  a high risk of bias due t  the sample siz  f one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bia Assessment tool outpu used to a sess the quality and the risk of bias 
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process, 2. deviations from intended in erventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which pr duces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to the randomization procedures being irrelevant to 
vali ation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bia Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-typ  study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which pro uces an overall bias re ult in the f rm of 
“Low risk”, “Some concerns”/unclear risk f bi s, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” f r bias d e to the ra domization procedures being irreleva t to 
validation-type study designs. One study had a high risk of bias t  the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from i tended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bi s, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedur s being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of on  (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output us d to assess the quality and the risk of bias 








































































































     















Technologies 2020, 8, x FOR PEER REVIEW 11 f 17 
 
process, 2. deviations from intended interventions, 3. missing o tco e data, 4. measurement f the 
outcome, 5. selection of the reported res lt), which produces an overall bias result in the f rm of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the ra domizatio  procedures bei g irrelevant to 
validation-type study designs. One st dy had a high ri k of bi s due t the ample ize of one (n = 1) 
(34). 
Table 6. Cochrane Risk f Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended i erventions, 3. missing outcome data, 4. measurement of the 
outco e, 5. selectio  of the repor ed result), which pr duces an overall bias result in the form of 
“Low risk”, “Some c ncerns”/ nclear risk of ias, and “High risk”, as een in Table 6. All the studies 
had at l ast “Some once ns” r bias e to the randomization procedures being irrelevant to 
vali ation-typ  st dy des gns. One st dy ha  a h gh risk of bia  due t  the sample size f one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bia Assessment tool outpu  used to assess the quality and th  risk of bias 
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process, 2. deviations from i tended in erventions, 3. mis ing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to the randomization procedures being irr l vant o 
vali ation-type st dy esigns. One st dy had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. C chrane Risk of Bia Assessment tool output us d to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended i terventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which pro uces an overall bias re ult in the form f 
“Low risk”, “Some concerns”/unclear risk f bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” f r bias d e to the ra domization procedures bein  i relevant to 
validation-type study designs. One study had a high risk of bias t  the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from i tended interventions, 3. mi sing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bi s, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to t e randomization procedures bein  i relevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of  (  = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output us d to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing o tco e data, 4. m a urement f the 
outcome, 5. selection of the reported result), which produces an overall bias result in the f rm of 
“Low risk”, “Some concerns”/unclear risk of bias, a d “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the ra domization procedures bei  i relevant to 
validation-type study designs. One st dy had a high ri k of bi s due t the ample ize of one (n = 1) 
(34). 
Table 6. Cochrane Risk f Bias Asse sme t too  output used to assess the q ality and the risk of bias 
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p cess, 2. deviations from inte d d i tervention , 3. is ing ou c me dat , 4. m sure ent of the
outcome, 5. sel cti  f the r p ted res lt), which produc  an ov rall bias re ult in the form of
“Low risk”, “Some concern ”/u le r i k of bia , an “High i k”, as seen in Table 6. All the studies
had at least “Some concerns” for bias e  the ran mi ation proced res being irrelevant t  
validation-type study des gns. On  study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Tabl  6. Coc rane Risk of Bias Assessment tool output s to assess the quality and the risk of bias 
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process, 2. deviations from i tended in erventions, 3. mi sing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias r sult in the form of 
“Low risk”, “Some concerns”/unclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to t e randomization procedures bein  i r levant to 
vali ation-type st dy esigns. One st dy had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. C chran  Risk of Bia Assessment tool output us d to assess the quality and the risk of bias 
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p o s 2. deviations fr m intend d intervention , 3. missing utcome data, 4. measurement of the 
outcome, 5. select o of rep rt d res lt), which produc s an overall bias re ult i  the form of 
“Low isk”, “Some concern ”/u clear r of bias, and “High risk”, as een in Table 6. All the studies 
had at l ast “S e conc rns” f r b as due to th  randomization rocedures being irrelevant to
va idation-type study d si ns. O e study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Coc r ne Risk of Bias Assessment tool o tput used to as ess the quality nd the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the randomization procedures being irrelevant to 
validation-type study d sig s. On  tudy had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outco e data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
had at least “Some concerns” for bias due to the ra domization procedures bei g irrelevant to 
validation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bias Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended in erventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to the randomization procedures being irrelevant to 
vali ation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bia Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended in erventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of ias, and “High risk”, as seen in Table 6. All the studies 
had at l ast “Some concerns” for bias due to the randomization procedures being irrelevant to 
vali ation-type study designs. One study had a high risk of bias due to the sample size of one (n = 1) 
(34). 
Table 6. Cochrane Risk of Bia Assessment tool output used to assess the quality and the risk of bias 
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process, 2. deviations from intended interventions, 3. missing outcome data, 4. measurement of the 
outcome, 5. selection of the reported result), which produces an overall bias result in the form of 
“Low risk”, “Some concerns”/unclear risk of bias, and “High risk”, as seen in Table 6. All the studies 
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The purpose of this rapid systematic review was to evaluate the current state of the literature and
to identify the types of study designs, wearable devices, statistical tests, and exercise formats used in
studies conducted n applied settings/outdoor environments. According to our findings, the present
volume of literature validating wearable technology in applied settings is small compared to the
larger body of wearable technology validation literature. We believe that determining the validity
and reliability of wearable technology devices in applied settings is important, (1) for consumers
to have confidence in the measurements that are being generated, (2) for coaches, practitioners,
and athletes to have accurate and reliable physiological data available, and (3) for researchers who
wish to conduct investigations in applied settings utilizing these devices. Our findings indicate two
main themes that should be considered when investigators intend to conduct validity or reliability
testing on wearable devices in outdoor settings. Each theme will be discussed in further detail below,
including considerations for study design, and for the analytical techniques utilized.
4.1. Study Design
Out of the nine papers that were included, only one paper analyzed the reliability of the
device [36]. Reliability is an important aspect in determining the effectiveness of wearable technology
and researchers should design validation and reliability studies to remedy this deficiency. This limitation
has been noted in other systematic reviews specific to wearable technology for tracking physical
activity [5,48]. The current findings, again, highlight the need for study designs to account for
device reliability.
A difficulty in outdoor validation is designing robust and complex training or testing protocols,
and authors should aim to design more rigorous and purposive studies to improve the level of testing,
similar to what would be found in laboratory-based studies. These may include utilizing different
intensities, modalities, environments, populations, and collection times, to name a few. Wearable
technology purports to measure physiological variables in a range of different exercises, however,
running, walking, and biking are the main exercise modalities evaluated, and there remains a need
to validate these devices using other modes of exercise. The Consumer Technology Association
recommends at least 5 min of data collection during trials obtaining heart rate [49], however, that may
still be insufficient. The average collection time for the studies included in this review was 25.1 min.
Researchers should also try to account for a range of body compositions, BMI, age, biological sex,
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skin type, etc., as the Consumer Technology Association also recommends [49]. Of the studies reviewed,
only one [38] reported BMI (although all reported height and weight, so the BMI could be calculated),
two [40,42] reported body fat percentage, and none reported skin types (although not all authors used
devices with photoplethysmography or near-infrared sensors that could be impacted by the skin type).
The Consumer Technology Association has also recommended that at least twenty participants be
utilized [49–51], and only 56% (5/9) of studies met this guideline.
These consumer devices are primarily going to be used at self-selected paces, consequently, it is
important to have a self-selected pace as a condition of the validity testing; however, researchers should
also make an effort to incorporate different intensities of exercise, as these devices are intended to be
used throughout the spectrum of exercise intensity. The studies included in the current review used a
self-selected pace in seven of the nine studies.
Researchers should also seek to validate the devices in a range of environments, including different
altitudes, temperatures, humidity levels, etc., whenever reasonable. When reporting the results of the
studies, researchers should also include information about the testing environment under which the
devices were utilized. The studies for the current review reported a range of environmental factors,
such as the testing surface, geographical region, temperature range, altitude, and grade. Designing
studies to test under these different conditions and circumstances will provide better resolution,
for both the consumer and the researcher, as to the unique circumstances and intensities in which each
device may be considered valid.
4.2. Analytical Techniques, Validity Criteria, and Quality Assessment
According to Welk et al. [10], 87% of the activity monitoring validation literature uses correlation
coefficients and 52% use MAPE. From the studies included in the present review, the use of multiple
statistical tests was performed in 88% of the validation studies. We recommend that researchers looking
to validate a device perform at least three analyses to assess validity, 1. some type of correlation test
(Pearson, Spearman, ICC, CCC), 2. MAPE, and 3. Bland–Altman plots with 95% limits of agreement.
MAE or root mean square error (RMSE) can also be useful as they are in the same units of the device
measurement [52–54], and some authors have seen fit to perform mean comparisons using standard
hypothesis testing methods (t-test, ANOVA) with a “flipped” alpha level to determine accuracy [10].
While this type of analysis can be useful in determining whether the device tends to overestimate or
underestimate, compared to the criterion measure, these tests were designed to determine whether a
difference exists, and a lack of a significant difference is not the same as accuracy or validity. Therefore,
statistical analyses using MAPE, correlation, and Bland–Altman plots should also be performed.
As discussed earlier, there is no widely accepted criteria to determine validity, and it varies
between authors, journals, and reviewers. Of the six studies that utilized MAPE as a criterion for
validity determination, a threshold of <10% was established for the validity threshold in two of
them, with the other four did not report a threshold. TEE or MAE was utilized in four investigations
with one study utilizing effect size calculation to determine validity, while the other three did not
establish thresholds for TEE or MAE. Five out of eight validation studies utilized Bland–Altman plots,
although there has not been a quantitative measure developed to establish thresholds associated
with Bland-Altman plots. Correlative measures were highly common, and performed in 8/9 studies
evaluated, with a minimum threshold for correlation values being >0.7 and a maximum threshold
of >0.9. While acceptable analyses are beginning to emerge, there remains the need to establish
universally acceptable validity criteria. As there is not even agreed upon criteria to measure accuracy
and validity, accepted thresholds to determine validity have even less consensus. As the purpose of
validation studies is to answer the question of whether a device is valid, thresholds to answer that
question are essential. While specific use cases of the devices may influence whether a given validity
threshold would be acceptable to certain populations (research, professional and collegiate athletics,
consumer use, etc.), it is, nevertheless, important to establish appropriate thresholds to determine
when devices may be considered valid.
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The deficiency of proper analytical methods extends to the evaluation of the quality of the articles,
as is evidenced in the lack of appropriate “Risk of Bias” assessment tools for a review such as this one.
While some systematic reviews for validation literature will use a common risk of bias tools like the
Cochrane [31] or Joanna Briggs Institute [55] assessment tools [56], others have simply chosen not to
perform a risk of bias assessment [11]. While the Cochrane tool was used in the current review, there is
a need to develop an assessment tool more appropriate to the study designs used in the validation of
wearable technology.
Beyond establishing appropriate measurement criteria, thresholds, and a proper risk of bias tool for
validation studies, there is no easy way for practitioners, researchers, athletes or consumers to determine
whether a device is valid, and under what circumstances it may be valid without combing through,
potentially, hundreds of peer-reviewed articles. This is time-consuming and difficult for anyone to do,
and even more unlikely for athletes or consumers to do, as they may not have access to certain articles
or journals. There is a need for an easily accessible, independent database to succinctly characterize
which devices may be used in specific scenarios, based on the independent, peer-reviewed validation
literature. This would be helpful for anyone seeking to use wearable technology, from consumers
using it for recreational fitness purposes to academics and professionals conducting high-level research.
As the capabilities of these devices to measure more physiological metrics inevitably improve, the need
for independent research will continue to increase. In addition to adding new activities, manufacturers
should also seek to continually improve the list of physiological variables that the devices can measure.
4.3. Limitations
A limitation of the current review is that Google Scholar does not allow the user to go past page
100 (1000 search results). This was not known to the researchers prior to starting the review, however,
due to the popularity of Google Scholar (as stated earlier, 82% of academics start their research using
Google Scholar) [32], the decision was made to move forward despite this limitation. The major reason
this review has been labeled a “rapid review”, was due to the search abilities associated with using
Google Scholar.
5. Conclusions
The purpose of this review was to evaluate the current state of the literature and to identify the
types of study designs, wearable devices, statistical tests, and exercise modes used in validation and
reliability studies conducted in applied settings/outdoor environments. As a result, we identified nine
studies that fit our inclusion criteria and reflected the current state of the literature. The main findings
included 28 wearable devices with exercise modalities in outdoor environments being: running, walking,
cycling, hiking, and trail running. There were not any universally common analytical techniques used
to determine validity, however, correlative measures were used in 88% of the studies, mean absolute
percentage error (MAPE) was used in 75%, and Bland–Altman plots were used in 63%. The devices that
had an MAPE lower than 10% and a correlation value of greater than 0.7 in any measured variable were:
Garmin Vivosmart (Energy Expenditure), Garmin Vivoactive (Energy Expenditure), Suunto Spartan Sport
w/HRM (HR), Garmin fenix 3 HR (VO2max), and the PulseOn (VO2max).
Overall, the current review established the need for greater testing in outdoor or applied settings
when validating wearable technology. Researchers should seek to incorporate multiple intensities,
populations, and exercise modalities into their study designs while utilizing appropriate analytical
techniques to determine validity and reliability. The results of these studies will have even greater
relevance when validated in the field or in applied settings. Researchers who perform the validation of
these devices enable others to confidently use these devices to drive training, health, and wellness
decisions, as well as to enable the use of these devices in future research.
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